Biolife Solutions Inc (NASDAQ:BLFS)
| Market Cap | $1.89B+42.4% |
| Revenue (ttm) | $102.82M+34.4% |
| Net Income | $50.45M+1012.2% |
| EPS | $1.02+979.4% |
| Shares Out | 48.86M |
| PE Ratio | 37.34 |
| Forward PE | 123.75 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 4,393,546 |
| Open | $37.16 |
| Previous Close | $38.61 |
| Day's Range | $37.00 - $38.83 |
| 52-Week Range | $17.86 - $39.76 |
| Beta | 1.92 |
| Analysts | Buy |
| Price Target | $31.00(-19.71%) |
| Earnings Date | n/a |
About BLFS
BioLife Solutions, Inc. (BLFS) operates as a global provider of specialized bioproduction tools and services, primarily catering to the cell and gene therapy industry. Its market reach extends across the United States, Canada, Europe, the Middle East, Africa, and other international regions. The company's offerings are essential for various stages of biologic-based therapy development, spanning from foundational and applied research to large-scale commercial manufacturing. Key products include proprietary biopreservation media, such as HypoThermosol FRS and CryoStor, which are engineered to minimize delayed cell damage and death typically associated with preservation. Complementing these are the ThawSTAR products, an automated line of devices for thawing vials and cryobags, designed to precisely manage the heat and timing for optimal biologic material thawing. BLFS also provides innovative cloud-connected evo shipping containers for the passive storage and secure transport of temperature-sensitive biologics and pharmaceuticals. Additionally, its comprehensive range encompasses liquid nitrogen laboratory freezers, various cryogenic equipment and accessories, and specialized storage services for biological and pharmaceutical products. Products are distributed both directly to customers and through a network of third-party distributors. Established in 1987, BioLife Solutions, Inc. maintains its headquarters in Bothell, Washington.
$BLFS stock is featured in our Congress Trading, and Insider Trades datasets.
→ All Stock ListsCongress Trading
Recent trades of BLFS by members of U.S. Congress
| Tom MalinowskiHouse | Purchase$1.00K – $15.00K | Jul 7, 2020 |
| Tom MalinowskiHouse | Purchase$15.00K – $50.00K | Jun 17, 2020 |
Recently reported changes in BLFS holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by BLFS's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
BLFS Estimated quarterly lobbying spending
Source: U.S. Senate LDA
U.S. Patents
New BLFS patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to BLFS from public contracts
Source: USAspending.gov
Top ETF Holders
ETFs with the largest estimated holdings in BLFS
| ARBAltShares Merger Arbitrage ETF | $1.64M |
| SLYSPDR S&P 600 Small Cap ETF | $1.39M |
| EVNTAltShares Event-Driven ETF | $312.61K |
| PQSGPGIM ETF Trust - PGIM QMA Strategic Alpha Small-Cap Growth ETF | $32.28K |
| ISCBiShares Morningstar Small-Cap ETF | $76 |
Estimated from each fund’s disclosed top holdings × AUM
Bull Case vs Bear Case
AI-generated from BLFS’s recent data — informational, not investment advice
What’s Behind the Score
Recent Insider Activity
Frequently Asked Questions
ETFs that hold this stock
| EVNT | AltShares Event-Driven ETF | 2.41% |
| ARB | AltShares Merger Arbitrage ETF | 1.62% |
| PQSG | PGIM ETF Trust - PGIM QMA Strategic Alpha Small-Cap Growth ETF | 0.25% |
| VIOG | Vanguard S&P Small-Cap 600 Growth ETF | 0.10% |
| VIOO | Vanguard S&P Small-Cap 600 ETF | 0.10% |
| VIOV | Vanguard S&P Small-Cap 600 Value ETF | 0.09% |
| VTWV | Vanguard Russell 2000 Value ETF | 0.09% |
| SLY | SPDR S&P 600 Small Cap ETF | 0.08% |
| VHT | Vanguard Health Care ETF | 0.02% |
Weight is the stock’s share of each fund’s holdings.
